Connect with us

Published

on

Canada’s University Health Network said its Toronto Western Hospital would be the first non-US site of a trial for a device created by Neuralink Corp., Elon Musk’s brain-implant company. 

“We are incredibly proud to be at the forefront of this research advancement in neurosurgery,” UHN Chief Executive Officer Kevin Smith said in an announcement. He also said UHN would be the “first and exclusive” site for the trial in Canada, but did not say when it would begin.

On Wednesday, Neuralink said that it had received approval from regulators in Canada to launch clinical trials for its device in that country.

“Health Canada has approved the launch of our first clinical trial in Canada!” the company posted on X, the social media service also owned by Musk. “Recruitment is now open.”

Neuralink added that it was seeking patients with Quadriplegia due to ALS, also known as Lou Gehrig’s disease, or spinal cord injury.

Health Canada didn’t immediately provide a comment.

For months, Neuralink has been recruiting patients in the US, UK and Canada, with links to a registry on its website. Other companies in the field, such as Synchron Inc., are recruiting for their own future trials.

Neuralink’s first product aims to allow patients to control external devices, such as computers, through their thoughts. Neuralink is also working on treating other conditions such as blindness, but that project is further away. In the distant future, Musk has said Neuralink could work with healthy patients on functions such as augmenting memory.

Its first human patient, Noland Arbaugh, was implanted with Neuralink’s device earlier this year, at the Barrow Neurological Institute in Phoenix.

© 2024 Bloomberg L.P.

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

Continue Reading

Science

Rare Giant Solar Tornado and Plasma Eruption Captured Together on the Sun

Published

on

By

A Romanian researcher captured a rare sight on the Sun — a giant solar tornado alongside a massive plasma eruption. Both events, driven by magnetic field changes, highlight the Sun’s extreme activity during solar maximum. Luckily, the eruption’s CME is not headed toward Earth.

Continue Reading

Science

Russia Launches Bion-M No.2 with Mice, Flies, and Seeds to Study Space Biology

Published

on

By

Russia’s latest resupply mission to low-Earth orbit has delivered a unique scientific cargo: 75 mice, 1,000 fruit flies, microbes, cell cultures, and plant seeds aboard the Bion-M No.2 biosatellite. Over the next month, these organisms will orbit Earth, helping scientists study how microgravity and cosmic radiation affect life. Some mice are genetically engineered t…

Continue Reading

Science

NASA’s Expedition 73: Astronauts Study Brain, Balance, and Immunity on ISS

Published

on

By

Astronauts aboard the International Space Station are conducting key health experiments as part of Expedition 73, focusing on how the brain and immune system adapt to microgravity. Crew members exercise to counter muscle and bone loss, complete cognitive tests, and practice emergency medical drills. Using virtual-reality equipment, they study balance in weightlessness…

Continue Reading

Trending